These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9646225)

  • 21. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of hepatitis C virus-related cirrhosis].
    Bronowicki JP
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of cirrhosis due to chronic hepatitis C.
    Everson GT
    J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
    Gutkowski K; Gutkowska D; Bilkiewicz T
    Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recommendations from a Swedish meeting of experts. Hepatitis C is to be treated with the combination of interferon and ribavirin].
    Wejstål R; Fischler B; Glaumann H; Norkrans G; Reichard O; Sönnerborg A; Uhnoo I; Weiland O
    Lakartidningen; 1999 Nov; 96(44):4795-8, 4800. PubMed ID: 10584541
    [No Abstract]   [Full Text] [Related]  

  • 28. Histological and nonhistological criteria in the evaluation of liver involvement in chronic hepatitis C.
    Mateescu RB; Rimbaş M; Stăniceanu F; Zurac S; Dragomir P; Voiosu MR; Tătaru M; Zota M; Bucurică S
    Rom J Intern Med; 2006; 44(2):117-30. PubMed ID: 17236293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of chronic hepatitis C and alcohol consumption].
    Mathurin P; Canva V; Dharancy S; Paris JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B248-51. PubMed ID: 12180297
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Sene D; Limal N; Piette JC
    J Rheumatol; 2005 Nov; 32(11):2078-82. PubMed ID: 16265682
    [No Abstract]   [Full Text] [Related]  

  • 31. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationships between pulmonary arterial hypertension and active chronic hepatitis].
    Zăgreanu I; Iancu A; Rusu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):565-8. PubMed ID: 44761
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous involvement of hepatitis C virus. Which future after new antiviral drugs?
    Yaccob A; Kridin K; Mari A; Fagoonee S
    G Ital Dermatol Venereol; 2020 Oct; 155(5):599-601. PubMed ID: 33295739
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis C therapy and anticonvulsants.
    Bartres C; Soy G; Forns X
    Gastroenterol Hepatol; 2021; 44(7):536. PubMed ID: 33253770
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary pulmonary hypertension and chronic liver disease].
    Fireman Z; Rock M
    Harefuah; 1982 May; 102(10):451. PubMed ID: 7160681
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatitis C virus-infected patients with a history of epileptic fits can and should be treated with standard therapy].
    González-Mendez Y; Hernández-Guerra M; Turnes J; Abreu I; García D; Quintero E
    Gastroenterol Hepatol; 2013; 36(7):494-5. PubMed ID: 23582217
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary hypertension and hepatitis C virus related cirrhosis.
    Perrone C; Paroli M; Morelli S
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):283-4. PubMed ID: 9646225
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reversible ageusia and hyposmia induced by interferon in a patient with chronic hepatitis C].
    Irigoien Aleixandre S; Castiella Eguzkira A; Fernández Fernández FJ
    Rev Esp Enferm Dig; 2003 May; 95(5):364-8. PubMed ID: 12828524
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term outcome of chronic hepatitis C treated with interferon.
    Hadziyannis SJ; Papatheodoridis GV
    Ital J Gastroenterol Hepatol; 1999; 31(6):459-61. PubMed ID: 10575562
    [No Abstract]   [Full Text] [Related]  

  • 40. HCV genotypes and breakthrough in patients treated with recombinant alpha interferon.
    Roffi L; Colloredo G; Brugnetti B; Bellati G; Ricci A; Scalori A; Antonelli G; Panizzuti F; Pozzi M; Pioltelli P; Mancia G
    Am J Gastroenterol; 1998 Sep; 93(9):1602-3. PubMed ID: 9732970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.